CGM for Management of Type 2 Diabetes in Pregnancy

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 564 participants.

Also called NCT06628453

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 564 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06628453
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06628453. Randomized; no masking; primary purpose treatment. Start 2025-04-08 (actual); primary completion 2029-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CGM for Management of Type 2 Diabetes in Pregnancy
Acronym
CGM2
Condition
Type 2 Diabetes Mellitus (T2DM)
Condition
Pregnancy
Intervention (Device)
CGM
Lead sponsor
University of Alabama at Birmingham (class: other)
Collaborator
National Institutes of Health (NIH) (class: US National Institutes of Health)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct06628453
Content hash
fd50958ecaf04d69a05cba915228f3136686f6ed2ecc4de7c1fba4b0ed00fb2f